J. Wai‐Kuo Shih

Xiamen University — China

Medicine · Health Sciences

32h-index6.1kcitations54works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(24), Hepatitis C virus research(19), Animal Virus Infections Studies(9), Liver Disease Diagnosis and Treatment(8), Hepatitis Viruses Studies and Epidemiology(8)

Publications54 total

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses
Science Translational Medicine·2017· 88 cited
Long-Term Efficacy of a Hepatitis E Vaccine
New England Journal of Medicine·2015· 369 citedOpen Access
Long-Term Efficacy of a Hepatitis E Vaccine ; 戊型肝炎疫苗的长期保护效果
2015
Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: Current genotyping of EV71 does not reflect their antigenicity
Vaccine·2012· 44 cited
Reply
Gastroenterology·2011· 1 citedOpen Access
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
The Lancet·2010· 789 cited
RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo
BMC Microbiology·2010· 25 citedOpen Access
A novel immunoassay for PreS1 and/or core-related antigens for detection of HBsAg variants
Journal of Virological Methods·2010· 20 cited
Humanized antibodies with broad-spectrum neutralization to avian influenza virus H5N1
Antiviral Research·2010· 8 cited
Induction of cross-reactive antibodies against mimotopes of H5N1 hemagglutinin
Veterinary Microbiology·2010· 2 cited
Prevalence of Hepatitis E Virus in Chinese Blood Donors
Journal of Clinical Microbiology·2009· 105 citedOpen Access
Antibody reactivity of conformational peptide mimics of a conserved H5N1 neutralization site in different fusion proteins
Archives of Virology·2009· 1 citedOpen Access
Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine
Vaccine·2009· 134 cited
Broad Cross-Protection against H5N1 Avian Influenza Virus Infection by Means of Monoclonal Antibodies that Map to Conserved Viral Epitopes
The Journal of Infectious Diseases·2008· 68 cited
Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants
Vaccine·2008· 29 cited
Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double‐stranded RNA
Immunology·2007· 35 citedOpen Access
Vigorous Hepatitis C Virus–Specific CD4<sup>+</sup>and CD8<sup>+</sup>T Cell Responses Induced by Protein Immunization in the Presence of Montanide ISA720 plus Synthetic Oligodeoxynucleotides Containing Immunostimulatory Cytosine‐Guanine Dinucleotide Motifs
The Journal of Infectious Diseases·2006· 16 citedOpen Access
Quantitative analysis of anti–hepatitis C virus antibody–secreting B cells in patients with chronic hepatitis C†
Hepatology·2005· 38 citedOpen Access
Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes
Journal of General Virology·2004· 55 cited
PCR‐probe capture hybridization assay and statistical model for SEN virus prevalence estimation
Journal of Medical Virology·2004· 3 cited
page 1 of 3Next →

Frequent Co-authors

Harvey J. Alter(17), Ningshao Xia(11), Jun Zhang(9), Richard Yuan-Hu Wang(7), Anthony E. T. Yeo(6), Richard Y.‐H. Wang(6), Takeji Umemura(6), Mun‐Hon Ng(5), Yasuhito Tanaka(5), Shyh‐Ching Lo(5), John L. Gerin(5), Yixin Chen(5), Shengxiang Ge(4), Kendo Kiyosawa(4), Qi Qiu(4), J. Wages(3), Yoshiyuki Nakatsuji(3), Dennis M. Wong(3), Junhui Xiong(3), Wenxin Luo(3)